Infective and thrombotic complications of central venous catheters in patients with hematological malignancy: prospective evaluation of nontunneled devices

被引:80
|
作者
Worth, Leon J. [1 ,2 ]
Seymour, John F. [3 ]
Slavin, Monica A. [2 ]
机构
[1] Peter MacCallum Canc Ctr, Dept Infect Dis, Melbourne, Vic 3002, Australia
[2] Royal Melbourne Hosp, Ctr Clin Res Excellence Infect Dis, Victorian Infect Dis Serv, Parkville, Vic 3052, Australia
[3] Univ Melbourne, Parkville, Vic 3050, Australia
关键词
CVC-related bloodstream infection; Thrombosis; Peripherally inserted CVC; Nontunneled CVC; Hematology; Surveillance; BLOOD-STREAM INFECTIONS; NOSOCOMIAL INFECTIONS; CELL TRANSPLANTATION; BONE-MARROW; LONG-TERM; SURVEILLANCE; PREVENTION; GUIDELINES; EFFICACY; RISK;
D O I
10.1007/s00520-008-0561-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Central venous catheter (CVC)-related bloodstream infection (CR-BSI) is a significant complication in hematology patients. A range of CVC devices may be used, and risks for the development of complications are not uniform. The objectives of this study were to determine the natural history and rate of CVC-related complications and risk factors for CR-BSI and to compare device-specific complications in a hematology population. An observational cohort of patients with hematologic malignancy was prospectively studied following CVC insertion. Participants were reviewed until a CVC-related complication necessitated device removal, completion of therapy, death, or defined end-of-study date. The National Nosocomial Infection Surveillance definition for CR-BSI was used. Overall and device-specific rates of infective and noninfective complications were calculated and potential risk factors were captured. One hundred six CVCs (75 peripherally inserted central venous catheters [PICCs], 31 nontunneled CVCs) were evaluated in 66 patients, over 2,399 CVC days. Thrombosis occurred in 16 cases (15.1%), exit-site infection in two (1.9%), and CR-BSI in 18 (7.5 per 1,000 CVC days). No significant differences were found when complication rates in PICC and nontunneled devices were compared. An underlying diagnosis of acute myeloid leukemia was negatively associated with CR-BSI (odds ratio (OR) 0.14, p = 0.046), and a previous diagnosis of fungal infection was associated with infection (OR 22.82, p = 0.031). CR-BSI rates in our hematology population are comparable to prior reports. A low rate of exit-site infection and high proportion of thrombotic complications were observed. No significant differences in thrombotic or infective complications were evident when PICC and nontunneled devices were compared. PICC devices are a practical and safe option for management of hematology patients.
引用
收藏
页码:811 / 818
页数:8
相关论文
共 50 条
  • [21] Thrombotic complications of central venous catheters in 287 children with cancer.
    Journeycake, JM
    Buchanan, GR
    BLOOD, 2002, 100 (11) : 276A - 276A
  • [22] INFECTION RISK FOR NONTUNNELED CENTRAL VENOUS CATHETERS, ACCORDING TO THE PLACEMENT SITE IN ICU PATIENTS
    Vakalos, A.
    Tassioudis, P.
    Tsigaras, G.
    INTENSIVE CARE MEDICINE, 2010, 36 : S394 - S394
  • [23] COMPLICATIONS OF LONG-TERM CENTRAL VENOUS CATHETERS IN HOSPITALIZED-PATIENTS WITHOUT MALIGNANCY
    WOLLSCHLAGER, C
    BONCZEK, R
    MANN, M
    VOTTO, J
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (04): : A397 - A397
  • [24] Mechanical and infective central venous catheter-related complications: A prospective non-randomized study using Hickman and Groshong catheters in children with hematological malignancies
    Biagi, E
    Arrigo, C
    DellOrto, MG
    Balduzzi, A
    Pezzini, C
    Rovelli, A
    Masera, G
    Silvestri, D
    Uderzo, C
    SUPPORTIVE CARE IN CANCER, 1997, 5 (03) : 228 - 233
  • [25] Mechanical and infective central venous catheter-related complications: a prospective non-randomized study using Hickman and Groshong catheters in children with hematological malignancies
    E. Biagi
    C. Arrigo
    M. G. Dell'Orto
    A. Balduzzi
    C. Pezzini
    A. Rovelli
    G. Masera
    D. Silvestri
    C. Uderzo
    Supportive Care in Cancer, 1997, 5 : 228 - 233
  • [26] CENTRAL VENOUS CATHETERS AND THROMBOTIC COMPLICATIONS - A COMPARISON OF 3 DIFFERENT CATHETER MATERIALS
    LINDBLAD, B
    EFSING, HO
    MARK, J
    WOLFF, T
    THROMBOSIS AND HAEMOSTASIS, 1981, 46 (01) : 318 - 318
  • [27] Peripherally inserted central venous catheters for patients with hematological malignancies
    Harter, C
    Egerer, G
    SUPPORTIVE CARE IN CANCER, 2004, 12 (11) : 815 - 816
  • [28] Peripherally inserted central venous catheters for patients with hematological malignancies
    C. Harter
    G. Egerer
    Supportive Care in Cancer, 2004, 12 : 815 - 816
  • [29] Early and Late Complications Related to Central Venous Catheters in Hematological Malignancies: a Retrospective Analysis of 1102 Patients
    Morano, Salvatore Giacomo
    Coppola, Lorenzo
    Latagliata, Roberto
    Berneschi, Paola
    Chistolini, Antonio
    Micozzi, Alessandra
    Girmenia, Corrado
    Breccia, Massimo
    Brunetti, Gregorio
    Massaro, Fulvio
    Rosa, Giovanni
    Guerrisi, Pietro
    Mandei, Franco
    Foa, Roberto
    Alimena, Giuliana
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2014, 6 (01):
  • [30] Complications of central venous catheters in patients with haemophilia and inhibitors
    Morado, M
    Jimenez-Yuste, V
    Villar, A
    Quintana, M
    Del Castillo, F
    Garzon, G
    Acitores, I
    Ibañez, F
    Sanjurjo, MJ
    Gago, J
    Hernandez-Navarro, F
    HAEMOPHILIA, 2001, 7 (06) : 551 - 556